Biotechnology FDA Conditionally Approves Expanded Use Of BeiGene’s Combination Drug For Certain Type Of Blood Cancer – BeiGene (NASDAQ:BGNE) Read more
Biotechnology PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe – PTC Therapeutics (NASDAQ:PTCT) Read more
